I n the future, innovation will likely focus on five key areas: long-acting formulations, oral delivery methods, multi-target approaches, combination therapies, and expanding the range of indications
This mechanistic overlap explains why combining them may not produce additive benefitsthe GLP-1 receptor agonist effect of Rybelsus is already maximal, and adding a DPP-4 inhibitor to preserve endogenous GLP-1 (which is already being mimicked by semaglutide) offers limited additional advantage
Medical spas and dermatology clinics use GLP-1 prescriptions alongside complementary treatments such as body contouring, radio-frequency (RF) microneedling, and even injectable biostimulators to aim for aesthetic changes, for example, facial volume loss, linked with rapid weight loss
Your healthcare provider will adjust your treatment plan accordingly to minimize the risk of low blood sugar
Why does medical supervision matter
Practical Prevention Strategies and Provider Monitoring Prevention centers on maintaining hydration, monitoring urinary symptoms, and avoiding behaviors that concentrate urine